Similar articles for PMID: 26406774

Year	Number of Results
2010	3
2011	1
2012	3
2013	4
2014	13
2015	34
2016	48
2017	38
2018	33
2019	39
2020	27
2021	18
2022	4
2023	6
2024	5
2025	0

1

Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review.

King JB, Bress AP, Reese AD, Munger MA. King JB, et al. Pharmacotherapy. 2015 Sep;35(9):823-37. doi: 10.1002/phar.1629. Pharmacotherapy. 2015. PMID: 26406774 Review.

2

Sacubitril/Valsartan (LCZ696) in Heart Failure.

Khder Y, Shi V, McMurray JJV, Lefkowitz MP. Khder Y, et al. Handb Exp Pharmacol. 2017;243:133-165. doi: 10.1007/164_2016_77. Handb Exp Pharmacol. 2017. PMID: 28004291 Review.

3

Dual Angiotensin Receptor and Neprilysin Inhibition with Sacubitril/Valsartan in Chronic Systolic Heart Failure: Understanding the New PARADIGM.

Lillyblad MP. Lillyblad MP. Ann Pharmacother. 2015 Nov;49(11):1237-51. doi: 10.1177/1060028015593093. Epub 2015 Jul 14. Ann Pharmacother. 2015. PMID: 26175499 Review.

4

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.

Hubers SA, Brown NJ. Hubers SA, et al. Circulation. 2016 Mar 15;133(11):1115-24. doi: 10.1161/CIRCULATIONAHA.115.018622. Circulation. 2016. PMID: 26976916 Free PMC article. Review.

5

First-in-Class Composite Angiotensin Receptor-Neprilysin Inhibitors (ARNI) in Practice.

Barghash MH, Desai AS. Barghash MH, et al. Clin Pharmacol Ther. 2017 Aug;102(2):265-268. doi: 10.1002/cpt.736. Epub 2017 Jun 21. Clin Pharmacol Ther. 2017. PMID: 28512738 Review.

6

Angiotensin receptor-neprilysin inhibitor (ARNi): Clinical studies on a new class of drugs.

Gori M, Volterrani M, Piepoli M, Senni M. Gori M, et al. Int J Cardiol. 2017 Jan 1;226:136-140. doi: 10.1016/j.ijcard.2016.06.083. Epub 2016 Jun 23. Int J Cardiol. 2017. PMID: 27378659 Review.

7

A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.

Nguyen E, Weeda ER, White CM. Nguyen E, et al. J Clin Pharmacol. 2016 Aug;56(8):936-47. doi: 10.1002/jcph.677. Epub 2015 Dec 30. J Clin Pharmacol. 2016. PMID: 26626162 Review.

8

Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.

Jhund PS, Claggett BL, Voors AA, Zile MR, Packer M, Pieske BM, Kraigher-Krainer E, Shah AM, Prescott MF, Shi V, Lefkowitz M, McMurray JJ, Solomon SD; PARAMOUNT Investigators. Jhund PS, et al. Circ Heart Fail. 2014 Nov;7(6):953-9. doi: 10.1161/CIRCHEARTFAILURE.114.001427. Epub 2014 Oct 2. Circ Heart Fail. 2014. PMID: 25277997 Clinical Trial.

9

The Role of Neprilysin Inhibitors in Cardiovascular Disease.

Mills J, Vardeny O. Mills J, et al. Curr Heart Fail Rep. 2015 Dec;12(6):389-94. doi: 10.1007/s11897-015-0270-8. Curr Heart Fail Rep. 2015. PMID: 26466607

10

Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure.

Marques da Silva P, Aguiar C. Marques da Silva P, et al. Rev Port Cardiol. 2017 Sep;36(9):655-668. doi: 10.1016/j.repc.2016.11.013. Epub 2017 Aug 23. Rev Port Cardiol. 2017. PMID: 28844335 Free article. Review. English, Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 26406774

235 results

Results by year